Abcam, ab172612, Anti-Wnt3 and Wnt3a antibody [EPR4920(2)]

Size: 100µL / 1mL
Rabbit Recombinant Monoclonal WNT3A antibody. Suitable for WB and reacts with Transfected cell lysate - Human samples. Cited in 27 publications.
Key facts
Host species:Rabbit,
Clonality:Monoclonal,
Clone number:EPR4920(2),
Isotype:IgG,
Carrier free:No,
Reacts with:Human,
Applications:WBSee reactivity dataSee the reactivity data table below for information on validated species and application combinations.,
Immunogen:The exact immunogen used to generate this antibody is proprietary information.,
Specificity:This antibody is specific for both Wnt3 and Wnt3a based on the fact that the immunogen sequence is 100% identical for both.

Product details:
This antibody was developed as part of a collaboration with Karl Willert's lab from the University of California at San Diego.
Patented technology
Our RabMAb
technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to
RabMAb® patents
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production
For more information, read more on
recombinant antibodies

Properties and Storage Information:
Form-Liquid, Purification technique-Affinity purification Protein A, Storage buffer-pH: 7.2 - 7.4Preservative: 0.01% Sodium azideConstituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA, Shipped at conditions-Blue Ice, Appropriate short-term storage duration-1-2 weeks, Appropriate short-term storage conditions-+4°C, Appropriate long-term storage conditions--20°C, Aliquoting information-Upon delivery aliquot, Storage information-Avoid freeze / thaw cycle

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
Wnt3 and Wnt3a both members of the Wnt family are secreted glycoproteins involved in several signaling pathways. Commonly known as Wnt3 and Wnt3a for simplicity they have an approximate mass of around 40 kDa. These proteins exhibit expression during development stages and in various adult tissues. They function mechanistically by binding to Frizzled family receptors activating downstream signaling cascades. Wnt3 is predominantly expressed in the central nervous system while Wnt3a shows wide expression across mesoderm and ectoderm tissues.
Biological function summary
Wnt3 and Wnt3a are key players in cell proliferation differentiation and migration. These proteins are part of the Wnt signaling complex which influences gene expression important for embryonic development and tissue homeostasis. The Wnt3 and Wnt3a promote stem cell maintenance and expansion by regulating transcriptional activators and repressors. Their role extends to maintaining cellular architecture through interaction with cytoskeletal elements.
Pathways
Wnt3 and Wnt3a are integral components of the canonical Wnt/β-catenin pathway and the Wnt/Ca2+ non-canonical pathway. Through these pathways they impact various biological processes essential to cellular growth and differentiation. Wnt3a often interacts with β-catenin a well-known mediator that influences gene expression by entering the nucleus. Both Wnts regulate pathways that include Dishevelled (Dvl) proteins highlighting their interconnectedness in cell signaling networks.
Alterations in Wnt3 and Wnt3a signaling contribute to cancer and neurodegenerative diseases. Abnormal Wnt/β-catenin signaling links to colorectal cancer where excessive β-catenin activity supports tumor growth. Moreover disrupted Wnt signaling can impact Alzheimer's disease pathogenesis through interactions with amyloid precursor protein and tau. These connections highlight how Wnt3 and Wnt3a influence disease states impacting therapeutic strategies targeting Wnt pathway components.